Podcasts about healthy lives

Interoperable? Try international. Join this continent-crossing conversation as we explore international digital health strategies and what learning about other countries' health systems can teach us about our own. Guests: Derek Ritz, Principal Consultant, ecGroup Inc. Liz Keen, Head of Clinical Governance - Transformation and Innovation, Infosys Consulting Learn More: Digital Health Canada: The Core Competencies of Health Informatics Changing the conversation on evaluating digital transformation in healthcare: Insights from an institutional analysis Fair Society, Healthy Lives (the Marmot Review) Episode Summary: 00:00 Introduction to Digital Health in Canada 00:44 Guest Introductions: Derek Ritz and Liz Keen 01:45 Career Journeys in Digital Health 06:43 Global Perspectives on Healthcare Systems 11:09 Challenges and Innovations in Digital Health 18:10 Lessons from International Healthcare Systems 22:33 The Future of Digital Health 34:37 Advice for Aspiring Digital Health Professionals 38:59 Co-Host Reflections Music: RetroFuture Clean and Breakdown, by Kevin MacLeod. Used under Creative Commons.  

Grab your FREE copy of our Guide to Decoding Your Dog's Energetics when you subscribe to our F.E.T.C.H. newsletter here: https://subscribepage.io/pHUcny Become a founding member of our F.E.T.C.H. membership! Learn more and join here: https://www.patreon.com/learnfetch In today's episode, Stacey and I tackle the topic of dental health! February is Dental health awareness month, so we wanted to share with you some different ways you can help support your dog's dental health through diet and other tools, and talk with you about why dental health is so critical to overall health - all through the FETCH Framework lens! Yes, we talk a lot about Raw Meaty Bones as nature's toothbrush for our dogs, but we go into so much more, and probably some things that might surprise you! If you've struggled with your dog's teeth, this episode is packed with tips ranging from: *What periodontal disease actually is, what symptoms to look out for, and why it's so important to catch it early *Foods that support the teeth (they may not all be what you expect!) *How to use Raw Meaty Bones (RMBs) + alternatives to RMBs *The role of probiotics in dental health *DIY toothpastes, our take on water additives *How to think about dental procedures, including detox support for anaesthesia And we'll share what has worked and hasn't worked in our own experiences with caring for Lucky and Ted. Dental health is something we often skip over, but it's such a critical component of our dogs' overall health and wellbeing. We hope you take away some useful tips to try with your own pup! Links to things we mention in the podcast: Book- There's a Mushroom for That!: Learn How Mushrooms, Cannabis, and Integrative Medicine Help Your Pets Live Long and Healthy Lives by Dr Robert Silver https://amzn.to/40JAW4Q (This is an affiliate link. If you choose to purchase through this link, I will earn a small commission at no extra cost to you, and this supports the podcast) DIY Toothpaste Recipes https://www.dogsnaturallymagazine.com/toothpaste-for-dogs/ Chirag Patel's Bucket Game https://www.youtube.com/chiragpatelconsulting Get in touch! https://instagram.com/mysticdogmama https://mysticdogmama.com https://instagram.com/hozho_hounds https://hozhohounds.com

In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews two sessions promoting healthy livers and asks panelists what they anticipate for #TLM2025. This last conversation starts with Jeff describing the session that moved him most and praising a panel that Mike co-chaired on Lifestyle Management of MASLD and MASH. Jeff spoke on this panel, and he describes the breadth and quality of speakers and topics. While Jeff spoke about social determinants of health, others discussed commercial, regulatory and lifestyle determinants, all intermixed with practical advice on managing patients' lifestyle issues. Finally, he comments on a presentation from Meena Bansal discussing several concurrent posters in the meeting that aligned with the discussion in the session.  After Jeff shares the content of the meeting, he comments on the large number of providers and industry executives who attended this patient-centered session. Roger notes a similar distribution of attendees at the Health Livers, Healthy Lives session on building momentum for prevention. In wrapping up the session, Roger does not share another presentation but notes how many modes of action have produced successful Phase 2/3 trial results. He notes that we may have 4-5 different modes of action available five years from now. In the rest of the session, panelists describe what they believe will be different and exciting at #TLM2025. Answers vary, but most focus on advances in drug development and/or NITs.

00:00:00 – Surf's Up: Season 5 Episode 26 - Last month, close to 8,000 hepatology stakeholders convened in San Diego for The Liver Meeting 2024. Hepatology Key Opinion Leader Naim Alkhouri, Novo Nordisk International Vice President for Medicines Michelle Long, and patient advocates Jeff McIntyre from the Global Liver Institute and Michael Betel from the Fatty Liver Alliance join Jörn Schattenberg and Roger Green to discuss highlights. 00:03:23 - Introduction and Groundbreaker - Highlights include recent travel, cultural events, and the Third Annual Primary Care Summit from the Fatty Liver Alliance.00:11:35 - Describing TLM2024 - Participants shared a word or short phrase they felt best captured their feelings about TLM2024. 00:14:51 - The ESSENCE Trial - Naim starts the session by describing ESSENCE, a Phase 3 trial of semaglutide in non-cirrhotic MASH patients, which he describes as "the most exciting news of the meeting." Panelists describe the benefits of this trial from a variety of perspectives. 00.22.49 - A Challenge to Trial Recruitment? - Roger asks the group whether the presence of two approved MASH medications that do not require biopsy will make recruiting clinical trials that require them more challenging. The group doubts this will not add a significant new challenge to already-challenging trial recruitment. 00:29:22 - Other keys in drug development - Naim begins a discussion of two topics: the value of synergy between resmetirom and the GLP-1 agonist, and the importance of different genetic polymorphisms in predicting the impact of drugs on specific patients. Michelle mentions a recent paper in Nature identifying distinct clusters of patients based on how their SLDs progress over time. Roger identifies two particular challenges in this area, one posed by Lean MASH and the other specific to Hispanics in the US. 00:34:42 - FGF 21s - Jörn highlights a paper from the later breaker session on efimosfermin alfa, an FGF-21 dosed q4w. Roger and Mike comment. To Jörn, this and other studies demonstrate the place FGF-21s are likely to have in MASH therapy.00:40:29 - FDA Corner and the Role of Surrogates - Michelle praises the FDA Corner session, particularly the agency's transparency and willingness to engage industry and academia in finding paths to move away from biopsy. She is optimistic about the scientific community coming together to address these issues. Jeff notes the pivotal role he believes patients must play in this process. 00:48:33 - Patient Insights - Mike describes a poster he presented (and was lead co-author), titled Patient Voice in MASH Initiatives:  Foundational Principles for the Conduct of Patient-Centric MASH Research. He lists the groups participating in this broad effort and the foundational principles that emerged. Michelle and Jörn share their thoughts on which principles have the greatest impact on them in clinical research. Jeff praises a panel that Mike co-chaired on Lifestyle Management of MASLD and MASH. He praises the breadth and quality of speakers and topics. He also comments on the large number of providers and industry executives who attended this patient-centered session. Roger notes a similar distribution of attendees at the Health Livers, Healthy Lives session on building momentum for prevention. 00:58:36 - Wrapping Up - Roger comments on the breadth of modes of action that have produced successful Phase 2/3 trial results. He notes that we may have 4-5 different modes of action available five years from now. In the rest of the session, panelists describe what they believe will be different and exciting at TLM2025.01:06:01 - Question of the WeekListeners and readers, What do you consider the most essential paper or theme of TLM2024??01:06:38 - Business ReportChanges coming in 2025 with SurfingMASH v2.0

We have a great show planned for you and will cover the best way to Feed Your Pets Medicinal Mushroom Extract. We will be joined by a true pioneer in the field.Guest: Dr. Rob Silver graduated in 1982 from Colorado State's College of Veterinary Medicine. He established one of the first integrative vet clinics in the USA in Boulder, CO in 1993. Since then, Dr. Silver has become a nationally recognized expert in veterinary herbal and nutraceutical medicines, medicinal mushrooms, veterinary CBD and cannabis therapeutics. He has adjunct faculty positions at Lincoln Memorial University, College of Veterinary Medicine, and Chi University, a College of Traditional Chinese Veterinary Medicine.Dr. Silver brings to the Real Mushrooms Science Team 40 years of practical clinical experience treating small and large animals with diet, acupuncture, nutraceuticals, botanicals, and medicinal mushrooms.NEW BOOK!!!! There's a Mushroom for That!Learn How Mushrooms, Cannabis, and Integrative Medicine Help Your Pets Live Long and Healthy Lives If your pet has allergies, this book will be a godsend, explaining what tests best determine sensitivities. This is the first step in controlling both food and seasonal allergies.Mushrooms and cannabis are effective tools in the treatment of cancer and other common, but difficult to treat, diseases our pets suffer from when conventional medicine fails.Listeners can save 30% off when using the code: Forever30 at check out when visiting Realmushrooms.com 

I posed the question, "Are You Ready to Change," in the first episode of the show on Oct. 10, 2021. It was meant for my audience, but it applied to me too - and still applies to me all this time later. Because even though the show has changed over time, from Fit Family Foundations to the Healthy Lives, Healthy Business Podcast. But I have changed so much more. In honor of this special milestone, I fondly recall how much I have changed along the way. So sit back, relax and ENJOY the show - and then do me a solid and subscribe to the show, so more people have the opportunity to learn that... Fitness Is Our Business.

Host Anthony O'Donnell sits down with Jean Olive, CIO of John Hancock, to discuss the company's impressive journey towards digital transformation and its focus on enhancing customer experience. Jean shares her engineering background and diverse industry experience, discussing John Hancock's mission to promote long, healthy lives through innovative initiatives like vitality behavioral insurance. The discussion covers the significant role of AI and data-driven strategies in revolutionizing underwriting, sales applications, and overall customer satisfaction.  In this episode, listen to how John Hancock is embedding AI into its applications, establishing a data lake to improve data governance, and moving towards cloud-based solutions. Jean emphasizes the importance of nurturing internal talent, creating a culture of continuous learning, and aligning the company's mission with employee and policyholder well-being.  Listen for insights on John Hancock's commitment to industry-shaping innovations, engaging talent, and modernizing infrastructure amidst a rapidly evolving technological landscape. Key Takeaways: Leveraging AI tools like GitHub and Power Apps, along with strong data governance and a data lake, enhances underwriting processes and customer satisfaction. Implementing a "build borrow buy" strategy and creating a culture of continual learning are critical for developing and retaining top talent in an evolving technological environment. Focusing on digital transformation, moving applications to the cloud, and closing mainframe data centers streamline operations and improve the customer experience.   Jump into the Conversation: [00:01:07] Introduction of Jean Olive and her role at John Hancock [00:06:47] Jean's experiences and how that has benefitted her in her role [00:09:12] What John Hancock is working on inventing now [00:12:08] How Jean and John Hancock are working on a seamless customer experience [00:15:48] How John Hancock is thinking about product development [00:16:56] Where AI fits in John Hancock's digital vision [00:21:14] Challenges related to preparing the data for AI [00:23:17] How the company is keeping people and culture first while innovating [00:28:36] How John Hancock is living up to their mission [00:30:07] Closing   Resources: Connect with Jean Olive: https://www.linkedin.com/in/jeantolive/ Check out John Hancock: https://www.johnhancock.com/index.html   If you are starting your digital transformation journey, check out these e-books:  How To Kick Off a PAS Modernization Project, the Right Way: Insights From a Veteran Project Manager https://hubs.li/Q02rP_6z0 Critical Resourcing Decisions that Ensure the Success of Your PAS Modernization Project https://hubs.li/Q02rP_D10 The Reality Behind SaaS Policy Admin Vendor Claims. A Roadmap to Success https://hubs.li/Q02rP_Jf0

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the first day of the Congress.Roger's first interview with Louise took place at the end of Thursday, the opening day of the formal Congress and the first day of research presentations and posters. She starts by describing the "really nice vibe" of the meeting, dampened by the fact that Stephen Harrison was not there, and is no longer with us.The first session Louise chose to discuss was the previous day's Patient Advocate session. To her, the key point was to learn a key question that every provider should share with every patient once a year. She mentioned briefly the one presentation from the day's General Session she was able to attend, a retrospective analysis of the predictive value of VCTE.Next, Louise discussed two sessions she attended that delivered powerful, somewhat novel messages. The first was a symposium sponsored by Novo Nordisk that looked at using the liver "to manage cardiometabolic side" through the liver "rather than focusing on liver disease." The second was the "Healthy Livers, Healthy Lives" presentation that presented "very startling figures" about healthcare costs and lack of productivity in the US and how and why India has targeted this disease aggressively. After Louise and Roger both commented on the building momentum in MASLD and mentioned why they believe this is happening, Louise noted how many conversations about AI and quicker population detection were occurring despite the lack of ability to act on these today. This let Roger recall his major takeaway from the Preview episode (S5 E17), which was the emerging importance of data development and large datasets. He mentioned a paper from the Karolinska Institute that Hannes Hagstrom discussed in that episode.

In this closing conversation, Healthy Livers, Healthy Lives Chair Jeff Lazarus and Surfers Jörn Schattenberg, Louise Campbell and Roger Green discuss the upcoming United Nations General Assembly side event and consider ways listeners can support the "Healthy LIvers, Healthy Lives" coalition.Jeff discussed this impact on global care when the World Health Organization develops and releases a global health sector strategy. One key goal in public health is to lobby for a MASLD strategy. To that end, Healthy Livers, Healthy Lives is holding a side event at the United Nations General Assembly meeting in mid-September.  00:40:41 - Presenting MASLD to politicians One challenge in educating policymakers about MASLD is that people do not die from MASLD. One recent example: policymakers did not respond to the spread of SARS-CoV-2 until COVID-19 produced massive numbers of deaths. When asked, Jeff draws the chain from MASLD to MASH to cirrhosis and end-stage liver cancer and notes that we are already seeing MASLD as a leading cause of liver transplant. Roger suggests that Jeff reframe the issue to be about how many people die with MASLD, not from MASLD. Jeff believes this simple change may change the dialogue.  00:43:06 - How listeners can support this initiative Roger asks Jeff how listeners can support the Healthy Livers, Healthy Lives initiative. Jeff suggests that we all be careful to name the disease and let people know how easily MASLD can be identified and treated. For those who work in related areas or help set policy for their organizations, make sure that MASLD is included and, whenever possible, linked to diabetes, obesity, and other relevant metabolic conditions.   00:44:58 - LiverAIM and exit. As his closing comment, Jeff discusses LiverAIM, the largest European Commission-funded liver project in 26 years. (Jörn and Maja Thiele, who is leading the 100,000-person randomized clinical trial, discuss this in Episode 15.) Roger commits to producing an episode on LiverAIM this fall.   After Jeff departs, Jörn restates the importance of working with colleagues like Jeff who can systematically develop public health approaches and drive policy change from the top down. Roger agrees that a top-down approach can be extremely valuable, but may have limits in primary care. He suggests that professional organizations also need to bring allied health providers into the dialogue. 

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss how the coalition came into existence and to describe two initiatves aimed at increasing early screening.Jeff starts the conversation by describing the "bit of a bubble" in which the MASLD community lives: great news and lots of excitement within, but very limited exposure to related metabolic specialties (endocrinology, primary care, cardiology) and limited awareness among the people and organizations that shape public health policy.Jörn adds that Jeff has been working for the last 4-5 years to create a multi-stakeholder coalition to promote liver disease to relevant professional societies and public health policy shapers. Jeff notes that patient advocates, clinicians, and professional societies each have a pivotal role to play in advancing liver care, particularly MASLD care.Healthy Livers, Healthy Lives is a coalition of four major professional organizations (AASLD, ALEH, APASL, and EASL) along with other partners, like the Indian National Association for the Study of the Liver (INASL), to raise awareness within the liver field and also other metabolic specialties. Jeff describes it as  "really trying to be an open, transparent, engaging, ambitious and aspirational coalition" with a light structure and just a few areas of focus over the next year: World LIver Day on April 19, the World Health Assembly, and the UN General Assembly.Louise asks about efforts to promote early screening that will help patients get care earlier in their disease progression. Jeff mentions two: a project to "double the diagnosis" over the next 3-4 years, and another project to identify all the concomitant conditions with sufficient cost of disease to merit screening everyone in that group. The latter will provide the kind of data to which public policy makers respond best.

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss why political will is so important in overcoming inertia and obstruction in global MASLD public health policy.Louise notes that she left NHS because of obstruction against earlier stage efforts to promote liver health and asks how to achieve these goals. To Jeff, it all depends on political will. He provides an example from viral hepatitis to prove his point.Roger asks how to motivate primary care practitioners who are overloaded with tasks they need to complete during short, overly scheduled patient visits.Jeff notes this is a challenge today, with a solution that lies in education that not only teaches about the disease but also stresses the cost of inaction. To Jeff, teaching FIB-4 to primary care and automating the algorithm to make it available in every electronic patient record is the minimum we should strive for today.Jörn focuses on the cost of inaction from a different direction: physicians who are afraid they will demoralize patients when they diagnose a disease with no available treatment. Jeff responds, "Do we not raise awareness because we don't have out-of-the-box solutions?" He goes on to describe different types of solution that might work for a patient, ranging from digital apps to linking patients to social agencies that can provide support and services. Jeff notes that "the field will need to change as we find more patients," due to increased demand on public health systems and social agencies.

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss some of the specific structural challenges that confront global MASLD public policy, along with some promising local activities. Louise observes that, in her experience, primary care practitioners appreciate the support that specialist nurses can bring in educating providers about the disease and patients about how to better support themselves. Jeff responds that these are good findings as individual cases, but to make major changes in the field, we need large-scale, top-down innovations. One thing that, oddly, works in MASLD's favor is that most patients with advanced MASLD will have concomitant diseases requiring involvement with other specialties. Today, teams are looking at system issues to find the largest, most intractable structural problems so that solutions can emerge. After that, "we'll start to see bigger and faster improvements in the field." Jeff talks about several positive things happening in New York. First, he mentions a New York Times article about junk food and how manufacturers target aggressive marketing to poor and marginalized populations, with the net result that these populations have processed and ultra-processed foods making up a large share of their diets. Also, a "visionary" health commissioner is creating a program, Healthy NYC, with the goal of increasing life expectancy by reducing specific diseases.MASLD is not part of the effort today but with clinician support. we can get there over time. Earlier, Jeff had commented about the ease of implementing the FIB-4 test. Now, Roger raises the issue again, this time mentioning that SurfingMASH guests from ex-US markets have mentioned that ALT is not a standard test in their countries and asks Jeff if MASLD is making progress here. Jeff discusses the debate around this issue.  

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss the value of the updated EASL/EASD/EASO MASLD clinical practice guidelines and consider the role of Big Data in early MASLD screening. Roger asks Jeff whether he considers the updated MASLD CPG a step forward. Jeff praises the guidelines as "amazing" and suggests that one reason is that EASD and EASO are partners in drafting and promoting them.Roger's next question to Jeff addresses the idea that Big Data can provide a set of common variables that will outperform FIB-4 in predicting which patients are at high risk of MASLD or MASH, as Hannes Hagstrom discussed in Episode 17 this year. Jeff believes we can use more data than only the FIB-4 today but that, in the long run,we need better biomarkers to simplify the system. Jörn adds that having historical blood tests will allow for that kind of analysis, which should be superior to FIB-4. Jeff points out the challenge: not all variables are collected in each country. Bottom line: the solution must be simple and realistic to apply in practice in different countries.  

00:00:00 - Surf's Up: Season 5 Episode 22  Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss Healthy Livers, Healthy Lives, a coalition of four major professional organizations (AASLD, ALEH, APASL and EASL) and other partners. This coalition works with other specialties to create global public health awareness and drive "top-down" solutions that are pivotal to stemming the MASLD Tsunami.  00:06:48 - The need for a MASLD public health coalitionJeff starts the conversation by describing the environment in which the MASLD community lives today: great news and energy within, but minimal exposure among related metabolic specialties and public health policy shapers. 00:11:55 -  Healthy Livers, Healthy LivesJeff describes the structure and goals of Healthy Livers, Healthy Lives.00:13:32 - Two initiatives to increase early screeningIn response to a question from Louise, Jeff mentions two efforts: a project to "double the diagnosis" over the next 3-4 years and another to identify all the concomitant conditions with sufficient disease cost to merit screening everyone living with that condition. 00:16:39 - Political will and structural changeLouise asks how we can overcome obstruction within the system to promote liver health. To Jeff, it all depends on political will, the energy that converts successful localized strategies into large-scale, top-down innovation. The solutions to the most significant, most intractable structural problems that evolve this way can drive "bigger and faster improvements in the field." 00:28:40 - Good things happening in New York In this context, Jeff shares how a visionary health commissioner in New York has created the Healthy NYC program to increase life expectancy by reducing specific diseases. 00:33:00 - The updated MASLD CPGJeff praises the updated MASLD CPG guidelines as "amazing" and suggests that one reason is that EASD and EASO are partners in drafting and promoting them.00:35:40 - Big Data-drive screening solutionsThis section explores whether and how Big Data can provide a set of standard variables that will outperform FIB-4 in predicting MASLD risk (see S5 E17). Jeff and Jörn identify the benefits and challenges of this approach.  00:38:38 - The upcoming U.N. General Assembly MASLD side eventHealthy Livers, Healthy Lives is holding this event at the U.N. General Assembly meeting in mid-September. The goal is to push the World Health Organization to develop and release a global health sector MASLD strategy.   00:40:41 - Presenting MASLD to politiciansOne challenge in educating policymakers about MASLD is that people do not die from MASLD. Sadly, large death counts produce public sector action, as we all saw with COVID-19. Suggestion: Reframing the issue as to how many people die with MASLD, not from MASLD, may make the story easier to tell.   00:43:06 - How listeners can support this initiative Roger asks Jeff how listeners can support the Healthy Livers, Healthy Lives initiative. Listen to hear Jeff's suggestions.   00:44:58 - LiverAIM and closing comments Jeff mentions LiverAIM, the largest European Commission-funded liver project in 26 years (see S5 E15). Jörn restates the importance of working with experts in developing public health approaches that drive policy change from the top down. Channeling Louise, Roger suggests that professional organizations need to bring allied health providers into the dialogue.   00:50:03 - Question of the Week Roger asks what listeners believe they can do in their own organizations and lives to support the goals discussed today.  00:50:36 - Business Report News on next week's session, Roger's office hours, and the Vault conversation.

00:00:00 - Surf's Up: Season 5 Episode 19During EASL Congress 2024, US-based Roger Green, conducted interviews with Mike Betel, Louise Campbell (twice) and Sven Francque from Milano. These interviews focused on the major MASLD themes and presentations at the event. 00:04:14 - Conversation with Mike Betel beginsOn Wednesday, the first afternoon of the meeting, Mike Betel joined Roger from the convention center. The first part of the conversation centered  on the Patient Advocate session that Mike chaired with Shira Zelber-Sagi. The session's goal was to discuss barriers to addressing unmet needs in a clinical setting and explore potential solutions. Mike's key takeaway: patients around the world are having challenges getting personal attention and time from their treaters. The rest of this interview touched briefly on other sessions Mike attended. 00:15:23 - First conversation with Louise Campbell Roger's first interview with Louise took place late on Thursday. She described the "really nice vibe" of the meeting, dampened by the fact that Stephen Harrison is no longer with us.The first session Louise chose to discuss was the previous day's Patient Advocate session. To her, the key point was to learn a key question that every provider should share with every patient once a year. She briefly mentioned the one presentation from the day's General Session she was able to attend:  analysis of the predictive value of VCTE.00:19:53 - Philosophically important presentationsLouise discussed two sessions that delivered powerful, somewhat novel messages. The first was a symposium sponsored by Novo Nordisk about how SLD treatment could "manage the cardiometabolic side...rather than focusing on liver disease." The second was the "Healthy Livers, Healthy Lives" presentation which presented "very startling figures" about SLD impact on US healthcare costs and productivity and how and why India has targeted this disease aggressively. 00:26:29 - Building momentum and energy around AI Louise and Roger both observed that momentum is building in MASLD and mentioned why they believe this is happening, 00:33:05 - Second conversation with Louise beginsTwo days later, Louise and Roger conducted a second conversation, which focused on her enthusiasm for the updated Clinical Practice Guidelines and their practical implications. 00:36:12 - CPG session implicationsLouise said this session had "blown her mind" with its forward-thinking style and recommendations. Her favorite point? The guidelines mentioned resmetirom even before it was approved in Europe.   00:44:07 - Thoughts about medicationsRoger suggested that CPG aligned broadly with the drug presentations in the Late Breaker and General sessions. Collectively, those highlighted drugs with an array of modes of action and strengths across the metabolic continuum.  00:46:09 - Thoughts about devicesRoger asked whether Louise believed that, over time, the diagnostic focus would shift from liver stiffness and CAP to in-office PDFF. Louise discusses why this might be difficult.00:51:48 - Conversation with Sven beginsThis conversation, which took place 90 minutes after the final gavel, started with Sven praising the "vibrant hepatology community" evident at the meeting. From there, the discussion covered the Clinical Practice Guidelines, major drug development presentations and other categories. The conversation is fairly short, but packed with information and insight. 01:06:42 - Question of the WeekRoger asks what kinds of support and education primary care will need to step into a leading role in treating SLD.01:07:13 - Business ReportPlans for the next month, growth of the SurfingMASH Community, a special surprise instead of the Vault.

After a six-month hiatus, I'm back on the airwaves - with a new name and focus for the show. On the "Healthy Lives, Healthy Business" Podcast, we will help fellow entrepreneurs, business owners and career-minded people empower their personal and professional success through health and fitness. A couple things remain the same though... We'll have a bunch of great guests...and we'll have lots of fun. So sit back, relax and of course... ENJOY! --- Send in a voice message: https://podcasters.spotify.com/pod/show/victor-fernandes46/message

This conversation focuses on how the new MASLD nomenclature might improve providers' explanations of MASH to patients. Louise Campbell describes new opportunities, while Meena Bansal describes how focusing on metabolism provides a richer opportunity for providers to explain to MASH patients why fat on the liver matters.Louise Campbell starts this conversation by discussing a new NHS program providing primary care centers with VCTE units they can use to screen patients for MASLD and MASH. She points out that this will provide a unique opportunity to present the new MASLD nomenclature to primary care and allied health providers in a way that connects immediately to diagnosing patients and educating them properly about their disease. She notes that at the patient level, the discussion is still likely to focus on excess fat on the liver but presents the idea of "fat" in a less stigmatizing way.Meena Bansal focuses more specifically on exactly how provider-patient conversations might change. For years, she suggests, physicians have written "hepatic steatosis" on patient charts, but then told patients they "just have a little fat on the liver." In her view, the new nomenclature will take the word "just" out of the discussion and present the "little fat on the liver" as part of a metabolic syndrome that requires treatment. She goes on to mention another source of excitement: the ability to consider MetALD patients as part of the same MASLD community and add them to Mt. Sinai's longitudinal patient registry, which will likely become a rich source of MetALD data.Earlier in the episode, Jeff Lazarus had mentioned his excitement at the growing role and publicity for the "Healthy Livers, Healthy Lives" initiative. Louise notes that increasing focus on liver awareness and awareness of the importance of liver health, as discussed in Season 5 Episode 2, aligns neatly with Meena's disease description and the new communication opportunities for new physician and allied health specialties.

This conversation ties up several issues related to MASH and the new MASLD nomenclature that the panel did not touch on earlier in the episode. These range from the impact the nomenclature might have on other elements of treatment to the impact of this effort over time. Finally, the panelists grade the process to date (they admit, their views might be a bit biased) and signs of success. Roger Green starts this conversation by asking what impact panelists believe the new MASLD nomenclature might have on NITs. From one perspective, Meena Bansal notes that it should have no impact given that NAFLD/NASH and MASLD/MASH map so similarly on top of one another. From a different perspective, Jeff Lazarus asks whether the nomenclature and accompanying guidelines from professional societies will result in more testing. The group aligns around the idea that patients living with Type 2 diabetes are an excellent target for increased testing with NITs given the high overlap of the two groups. Maru Rinella comments specifically that all efforts to tie T2DM to MASLD as frequently common metabolic diseases will be helpful and that discussing the proper use of NITs might be one way to make this connection. Louise Campbell agrees that increased focus on "Healthy Livers, Healthy Lives" will drive exactly these kinds of discussions. The rest of the episode consists of Roger asking panelists three questions, to which they respond: What might change over the next year or two? Meena believese that approval of a drug will drive significant growth in the learning curve and, with that, enhanced disease awareness and understanding. Jeff suggests that this will not take the form of a transition from NAFLD to MASLD, but instead that people first learning about the disease will use the new nomenclature properly. Mike Betel notes that on the Fatty Liver Alliance website, ~98% of searches are simply for "fatty liver disease." Over time, he anticipates this will change and also that websites like FLA will address "fatty liver" queries in terms of new nomenclature. Impact on ICD codes. Meena, who is doing significant work in this area, answers that the goal is to have no impact but simply a smooth cutover. How the group would grade its work on this activity to date. As Jeff notes, answers from the people who led the process are likely to be quite biased, but all gave fairly high grades. 

News

Gareth O'Callaghan talks to Sinead Crowe of Intuitive Eating Ireland about a better way to get a healthy body. Hosted on Acast. See acast.com/privacy for more information.

Surfing the MASH Tsunami kicks off its 2023 wrap-up conversations with Jeff Lazarus, the 2023 winner of the Distinguished Scientific Achievement Award from the American Liver Foundation. He discusses three core MASLD-related opportunities for which he played a key role in 2023: the Research in Action initiative, the new MASLD nomenclature process and the Healthy Livers, Healthy Lives coalition.Most of this discussion focuses on Jeff's work leading the Research in Action coalition. As Jeff notes, this was the first time the MASLD "field has set its own agenda." Absent governmental or not-for-profit agencies driving the discussion, a group that has grown to over 400 collaborators published its own action agenda in AASLD and EASL publications. Jeff discusses the process through which he built this consensus, focusing on domains identified in earlier meetings: (i) treatment and care; (ii) models of care; (lll) increased awareness; and (iv) leadership. Jeff feels the legitimacy of this activity comes from "casting the net wide" with a series of Wilton Park meetings and from demonstrating how far MASLD lagged behind other non-communicable diseases in terms of goal development, structured support and public presence. Another key element in the initiative's success was a side event at the World Health Assembly led by the four major hepatology organizations, including not only AASLD and EASL but also APASL, and ALEH. Efforts to create parity with other non-communicable diseases will result in increased funding and "massive" increases in awareness.Today, the other NCDs mention other related metabolic diseases but not MASLD or MASH. Another example of the lack of urgency around MASLD: NIH just put out a call for funding for HIV, which Jeff notes might not be as high a priority in 2024 as MASLD.At this point, Jörn Schattenberg joins the conversation to congratulate Jeff on his recognition and award and also to discuss how important it is to the entire community that Jeff plays the role he does. In response, Jeff comments that one benefit of the Award is that it ratifies the importance of the kinds of consensus building and application of public health initiatives in MASLD space.From here, Jeff and Jörn step further forward to discuss the importance of funding prevention and education programs, done by governments in the EU and perhaps public or private players in the US. Jörn discusses the multidisciplinary nature of the Barcelona meeting they co-chair and how it provides outreach beyond hepatology. Jeff continues the thought to discuss the importance of social determinants of health (for example, food insecurity) in a world where healthy foods cost far more than more common alternatives (basmati rice costs 3x basic white rice).Roger asks how the new nomenclature is proceeding. Jeff says it is doing quite well in that there is significant global buy-in. Major centers around the world are adopting the new nomenclature for their meetings and clinics, but, Jeff notes, it is difficult for physicians to explain the disease to patients without using the words "fat" or "fatty."As the conversation winds up, Jeff notes the importance of bringing primary care to the education and outreach processes and the goal of doubling the number of patients screened over the next four years. The conversation closes on this note: much that must be done, but confidence that the energy to achieve these big goals is coalescing properly.

The most pressing global health threat you may not have heard about yet, with Jeffrey Lazarus (Episode 20) Join host Laura Meoli-Ferrigon on this episode of the Making Public Health Personal podcast with our esteemed guest Jeffrey Lazarus. He is a professor of global health in the Health Policy and Management Department at CUNY SPH, and a research professor at the Barcelona Institute for Global Health (ISGlobal) in Spain. His decade-long career as a health systems, HIV and viral hepatitis expert at The World Health Organization's Regional Office for Europe was followed by three years at the Global Fund to Fight AIDS, Tuberculosis and Malaria. He currently serves as co-chair of the HIV Outcomes Beyond Viral Suppression coalition, a member of the board of directors of the SHARE Global Health Foundation and as a member of the Global NASH Council and the EASL Public Health and Policy Committee, where he leads the global Healthy Livers, Healthy Lives coalition. Professor Jeff is the author of more than 300 publications centered around liver health, viral hepatitis, HIV and COVID-19. In today's episode, we'll discuss the most prevalent liver disease in human history, and why it is largely unknown to the general population. Formerly referred to as non-alcoholic fatty liver disease, metabolic dysfunction–associated steatotic liver disease (MASLD) affects an estimated 38% of the global adult population, and around 13% of children and adolescents. Professor Lazarus sheds light on the significance of assigning a new name and diagnostic criteria to this disease. Discover preventive measures, reversal strategies, and the need for integrative services to transform global liver health. Join us for an eye-opening conversation, and learn how we can combat this silent epidemic. Episode Links: Learn more and connect with Jeffrey V Lazarus: https://sph.cuny.edu/about/people/faculty/jeffrey-lazarus/ Professor Jeff's Twitter: https://twitter.com/jvlazarus?lang=en Professor Jeff's LinkedIn: https://www.linkedin.com/in/jeffrey-v-lazarus-42a86a/ American Liver Foundation Honors Professor Jeffrey V Lazarus, PhD with the Distinguished Scientific Achievement Award: https://liverfoundation.org/resource-center/blog/american-liver-foundation-honors-professor-jeffrey-v-lazarus-phd-with-the-distinguished-scientific-achievement-award/ Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa: a pragmatic cluster-randomized, controlled trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01573-8/fulltext A multisociety Delphi consensus statement on new fatty liver disease nomenclature: https://www.journal-of-hepatology.eu/article/S0168-8278(23)00418-X/fulltext NAFLD — sounding the alarm on a silent epidemic: https://www.nature.com/articles/s41575-020-0315-7 It is time to expand the fatty liver disease community of practice: https://journals.lww.com/hep/fulltext/2023/11000/it_is_time_to_expand_the_fatty_liver_disease.2.aspx A global research priority agenda to advance public health responses to fatty liver disease: https://www.journal-of-hepatology.eu/article/S0168-8278(23)00323-9/fulltext Download a transcript of this episode for accessibility: https://www.dropbox.com/scl/fi/fd3rlkerereywwbhgu6am/Ep20-Transcript.docx?rlkey=f5ml0aoumgrt71piugp182kri&dl=0

Passage of the Affordable Care Act in 2010 proved to be the catalyst for Cain Hayes' pivot from the financial services sector to health care.“What I saw is that people would oftentimes do a great job of building financial health in retirement only to get to retirement and have a poor quality of life,” said Hayes, now president and CEO of Point32Health. Hayes details his experience in the industry, including how he stays focused and positive when encountering major obstacles, in this episode of the PNC C-Speak podcast.Listen to the episode to hear more about:How Point32Health defines and addresses health equity.Why Hayes, a self-described optimist, subscribes to the late Colin Powell's definition of optimism.His fondness for baseball – “the ultimate team sport.”Powered by PNC Bank.Download a transcript of the podcast.

Brett Miller, Director of Operations at telaGen, joins Kelsey in this episode of Business Ninjas where they talk about birth tissue donation and how it can help rebuild healthy lives. telaGen helps mothers provide the gift of donation to donor recipients. It was created to expand the opportunity for mothers to give the gift of healing to those in need. telaGen is dedicated to launching and developing new birth tissue donation programs with their partner OBGYNs and hospitals. This will provide more patients in need the ability to receive donated tissues to aid in their healing journey. telaGen's vision is to be the premier provider for birth tissue donation programs for patients and communities throughout the nation.Learn more: https://www.telagenllc.com/ -----Do you want to be interviewed for your business?  Schedule time with us, and we'll create a podcast like this for your business:  https://www.WriteForMe.io/-----https://www.facebook.com/writeforme.iohttps://www.instagram.com/writeforme.io/https://twitter.com/writeformeiohttps://www.linkedin.com/company/writeforme/ https://www.pinterest.com/andysteuer/Want to be interviewed on our Business Ninjas podcast? Schedule time with us now, and we'll make it happen right away! Check out WriteForMe, more than just a Content Agency! See the Faces Behind The Voices on our YouTube Channel!

Are the buildings we live and work in supporting our wellness – or are they making us sick? Listen in as we pull back the curtain on 'sick buildings' and the adverse health impacts of traditional building design. Our expert panel features Professor Joseph G. Allen, the mind behind Harvard's Healthy Buildings Program, who enlightens us about the nine pillars of a healthy building and why they are critical to our well-being. We're also joined by Jim Dobbie and Debra Wyatte from Zeal for Living, who are revolutionizing the rental market by prioritizing health-focused living spaces. This episode uncovers the urgency of transforming our built environment and how this ground-breaking movement is setting a new standard for the future of living spaces.To learn more, visit Joseph G. Allen's site at hsph.harvard.edu/joseph-allen and Zeal for Living at ZealForLiving.com.Resources:Book: Healthy Buildings, How Indoor Spaces Can Make You Sick or Keep You Well by Joseph G. AllenHarvard T.H. Chan School of Public HealthHealthy Buildings Program at Harvardzealforliving.comJoseph G. Allen on TwitterJim Dobbie on LinkedInDebra Wyatte on LinkedInHosted by Kim MarshallProduced by Nova Media

The climate is in crisis.Low-income groups are disproportionately impacted in health.Racial minority students struggle to enter the STEM field.While these topics may appear unrelated, Biogen is at the intersection of all three. From approaching the climate crisis as a health crisis through Healthy Climate, Healthy Lives – its $250-million, 20-year commitment – to investing in STEM education and development of young students underrepresented in STEM, Biogen is at the forefront, applying its scientific expertise and resources to address health equity and STEM representation.We invited Johanna Jobin, Global Head of Corporate Reputation & Responsibility at Biogen and Executive Director of Biogen Foundation, to discuss Biogen's approach to CSR and ESG and the victories they've accomplished along the way.Listen for Johanna's insights on:How to operationalize and integrate ESG across your organization.How to develop a strategic and measurable ESG initiative – and act on it.Why it's vital to engage legal teams in ESG work and how to foster a relationship for long-term harmony.What to look for when building your ESG team of do-ers.Resources + Links:Johanna's LinkedInBiogen's Year In ReviewHealthy Climate, Healthy LivesBiogen FoundationBiogen Community LabBiogen Foundation and Community Lab's 20th Anniversary (00:00) - Welcome to Purpose 360 (00:13) - Biogen (02:50) - Meet Johanna (04:44) - Lessons and Secrets (08:13) - Inspiration (09:40) - Healthy Climate, Healthy Lives (13:12) - Size of Commitment (15:29) - Innovation Challenge (18:16) - Collaborations (21:55) - Community Lab (26:47) - Community Lab 2.0 (28:59) - Transparency in Reporting (33:36) - Working With Legal (35:46) - Insights (39:03) - Last Thoughts (41:18) - Wrap Up

Join Pastors Josh and Jenaye as they kick off the "Family Values" series! The "Family Values" series explains each of Evangel's core values. These values apply to any believer and can be used as an internal audit for any follower of Jesus.In this episode, Pastors Josh and Jenaye talk in-depth about the heart and vision behind the value "Inside Out." This core value focuses on leading a healthy life out of the overflow of a healthy heart.

Tracy Pedrotti from the Arizona Family Health Partnership discusses the importance of prioritizing adolescent health. Recorded from the Arizona Child Sexual Abuse & Exploitation Prevention Coalition meeting held on 8/30/21.

Don't be ashamed to say no --- Send in a voice message: https://anchor.fm/mirna66/message Support this podcast: https://anchor.fm/mirna66/support

May 29, 2022 Steve Barbee

Have you ever felt as though your smartphone use was getting a bit out of control? A new Canadian study is showing promise with curbing unhealthy phone habits; The work is called Healthy Screens. A team based at McGill University is part of the Healthy Brains for Healthy Lives initiative. Jay Olson is the project lead.

The Blue Zones® are the 5 places throughout the world where people live the longest, healthiest lives. They share similar habits: People in those 5 areas manage stress well, eat a mostly plant-based diet, and stay active and lean into their senior years. I discovered a simple Blue Zones® secret that you can implement to get healthier and live longer. Here, I'll show you how Blue Zones® folks move more (hint: it doesn't involve hours in the gym), why the number of calories you burn on the treadmill isn't accurate, the NEAT way to burn calories (and why this is a game-changer), how fidgeting might be the secret to burning more calories, plus easy ways to move more throughout your day for longevity and living healthier.

Dr. Lesley Fellows is a neurologist and Professor in the Department of Neurology & Neurosurgery at The Neuro (Montreal Neurological Institute-Hospital). Her clinic at The Neuro provides care to people living with a range of cognitive disorders, including Alzheimer's disease, as well as young-onset and other less common forms of dementia. She is head of the Cognitive Neuroscience Research Group at The Neuro, a theme leader for the Healthy Brains, Healthy Lives initiative at McGill, and serves as Vice Dean, Academic Affairs in the Faculty of Medicine & Health Sciences. Dr. Fellows talks about the brain, how it works and how to keep it working as optimally as possible, even after a diagnosis of dementia. Original air date: April 27, 2022 McGill Cares is a webcast series designed to support informal caregivers. During candid, 30-minute interviews with leading experts, Claire Webster, Alzheimer Care Consultant and Founder of the McGill Dementia Education Program, explores topics related to caring for a loved one with dementia. For more information about the McGill Dementia Education Program or to make a donation, please visit www.mcgill.ca/dementia. If you have specific topics or questions that you would like us to address during our weekly webcasts, please email us at dementia@mcgill.ca.

This episode brings back previous guests and features a new interview with Christine Hamann, Director of the Teaching Kitchen Collaborative, to talk about cross training and collaboration. It continues our series of episodes that consider how to effectively introduce the food knowledge outlined in the first half of the season into a health care context. Christine references two conferences in this episode:Healthy Kitchens, Healthy Lives (next event is in February 2023)Teaching Kitchen Research Conference (next event is in October 2022)We feature clips from these previous episodes:Telehealth and Provider Consultations (Season Two)Food Access and Health Care Season Finale (Season Three)How to Cook (Season Four)Bonus Intro: Designing Better Health Systems (Season Four)Putting Appreciation Into Practice (Season Four)The podcast narrative also draws on background conversations I had with:The Maven Project (see also the VPQHC telehealth office hours they participated in last year for discussion of their work)Cara Feldman-Hunt - Integrative Health and Wellness Coaching CertificateStephanie Gall -  Vermont Academy of Nutrition and Dietetics and UVM HN clinical nutritionFinally, if you want to learn more about the questions around nutrition education as part of medical training, the Center for Health Law and Policy Innovation published a report in 2019, Doctoring Our Diet, and the proposed resolution referenced from Rep. McGovern is found here. Full season archive here. This podcast is part of the Food Access in Health Care program at Bi-State Primary Care Association.  This season of Policy in Plainer English is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $189,892.00 with 0 percentage financed with non governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.

Welcome to episode 49  of the Today is the Day Changemakers Podcast. This week's  guest is Pam Ahern, Founder of Edgar's Mission in Lancefield, Victoria, Australia. Pam shares her incredible journey from packing lolli's ,as she calls them in a factory, and being a champion equestrian, to providing shelter and direct care for homeless, abused, injured and abandoned farm animals. You will quickly learn that kindness is at the heart of everything Pam does. When a little pig named Edgar Alan came into Pam's life it brought her down a path she never imagined. This is truly an incredible story and one that even involves the actor, James Cromwell, from the hit movie “Babe”.  Pam gave up her full-time job, hung up her riding boots, and dedicated her life to the protection of farm animals. Why, you may ask? Well you will need to listen in to hear why Pam built the 153 acre sanctuary that is currently caring for 500 farm animal residents. Every animal that comes through the sanctuary doors is given a special name, treated as an individual, and surrounded by so much love. Many that arrive are in need of immediate and very special care. The one thing that is truly amazing is how some of the animals support their counterparts who are in need of that additional help and support. You will hear about Vet Nurses Ruby the dog and Tabitha the cat.  You will fall in love with Calvin Swine, Mr. Invisible, Captain Kirk the Rooster, Smudge, and so many more as you watch them through their videos via FB and Instagram. Visit the Today is the Day YouTube Channel to see pictures of these special animals and Edgar's Mission.  Pam is also the proud Australian ambassador for World Animal Day and was a 2014 Victorian Local Hero Finalist in the Australian of the Year Awards. On top of all of that she is also the author of the book, 'The Gift of Kindness – True Stories of Rescue Farm Animals'. She shares an incredible mantra, "If we could live happy and healthy lives without harming others, why wouldn't we?" Listen in to hear Pam's incredible answer to, 'if I knew then, what I know now'.  Pam is the only one in all 49 episodes with this answer!Next week my guest is John Belizaire. John is the CEO of Soluna. John is a serial entrepreneur that has taken companies truly to the next level. When he was 28 years old, he sold his first start-up company for $150 million. Please subscribe, write a review and share the Today is the Day Changemakers Podcast.  Like us on Facebook and Instagram. Visit todayisthedayliveit.com for more information about this podcast and other programs available through Today is the day. I am also the CEO and Co-founder of the Zzak G. Applaud Our Kids Foundation. Connecting children and young adults ages 7-22 who meet the financial needs requirements with ongoing lessons in dance, acting, instrumental music, and vocal instruction. For more information visit applaudourkids.org. Don't forget to subscribe, like and share this podcast. You never know who needs to hear the messages that are shared here. Everyone has the opportunity to be a changemaker! Have a great week everyone!

Beth Archer, Executive Director of AgrIInstitute, shares how her organization is working to build the leadership capacity for adults in agriculture. Beth provides information about the Indiana Agricultural Leadership Program and the upcoming collaboration with the Indiana Rural health Association and Purdue Extension, "Healthy Minds, Healthy Lives". For more information, please visit the AgrIInstitute website: https://www.agriinstitute.org/

I went to the Healthy Kitchens, Healthy Lives conference in Napa, California, and found out that practically all the doctors there ate one thing every single day. Hear more about it!

2021.07.25.AM-Live as Light-Living Healthy Lives

Allison and Julia will cover the new underage drinking prevention campaign "Small Talks" from how this campaign came to be to what parents and caregivers need to know to start the conversations about underage drinking. We will discuss brain science as it relates to young brains, different approaches to when and how to talk with kids in your life and how your coalition or community group can build on this effort to adopt evidence-based policies and practices. Guests: Allison Weber & Julia Sherman Allison Weber is a Prevention Coordinator at the Wisconsin Department of Health Services in Madison, overseeing the Substance Abuse Block Grant (SABG) prevention set-aside. She has been involved in substance misuse prevention activities for over 15 years beginning in the frontline provider area in PA. She also was Director of Community Relations and Development at a large Latino non-profit in PA for many years. Weber served on numerous Boards of Directors and coalitions including the county Health Improvement Partnership and the local Federally Qualified Health Clinic (FQHC). Julia Sherman coordinates the Wisconsin Alcohol Policy Project at the University of Wisconsin Law School. In 2001, she began her work in alcohol policy at the American Medical Association's Office of Alcohol and Other Drug Abuse in Chicago and later served as the national Field Director for the Center on Alcohol Marketing and Youth. In 2009 Sherman chaired the Alcohol, Culture and Environment Work Group of the Wisconsin State Council on Alcohol and Other Drug Abuse and authored its final report, Changing Wisconsin's Alcohol Environment to Promote Safe and Healthy Lives. In 2010, she became the first coordinator of the Wisconsin Alcohol Policy Project at the University of Wisconsin Law School. Find more webinars here: www.yourchoiceprevention.org/webinars --- Support this podcast: https://anchor.fm/preventthis/support

Cody Hanson is the Founder and Licensed Professional Counselor at Rivertown Wellness. He has a heart for helping men become self-aware leaders - of themselves, their families and their teams. In this episode Cody explains - What counseling / therapy is, how it's different from mentorship / coaching, how to decide when you need a professional counselor, how counseling can help even if you feel pretty "healthy", and why incorporating faith into counseling as a believer is absolutely critical. Learn more about Rivertown Wellness - http://rwcincy.com/ Join the Grown Man Community - https://www.grownmanproject.com/community --- Send in a voice message: https://anchor.fm/grownman/message

Tanna is joined with health and lifestyle coach and fitness instructor, Amber Arrington. Amber brings her southern charm and creative coaching energy to the taboo subject of health and wellness. Amber gives us some great tips to help us live healthy lives, both physically and mentally, on purpose.

Welcome to Neural Pathways: Where Your Neuroscience Degree Can Take You, a podcast series presented by Healthy Brains, Healthy Lives at McGill University. Join in as host Rana Ghafouri, a current McGill neuroscience Master's student, sits down with neuroscience alumni to learn about the diverse career paths after graduate studies in neuroscience. Music: Awaken by Osaze

Dr. Jennifer Haythe, MD, is a Women's Health Expert, as well as a leading Cardiologist and Assistant Professor of Medicine at Columbia University Medical Center that helps people take control of their bodies and save their lives.  She specializes in pulmonary hypertension, heart failure, and women's heart health. Dr. Haythe finds her motivation and determination through the strong patient and family relationships she has forged, and the gratification of helping her patients get a new life. Dr. Haythe lives and practices in New York City and when not working, she enjoys an active lifestyle that includes running, boxing and yoga. Visit www.columbiadoctors.org/prof/jhhaythe. Get the Off the Grid Into the Heart CD by Sister Jenna.  Like America Meditating on FB & follow us on Twitter.  Download our free Pause for Peace App for Apple or Android.